Biofrontera Q2 EPS $(7.23) Misses $(5.14) Estimate, Sales $5.85M Miss $5.86M Estimate
Portfolio Pulse from Benzinga Newsdesk
Biofrontera reported Q2 losses of $(7.23) per share, missing the analyst consensus estimate of $(5.14) by 40.66%. This is a 50.63% decrease over losses from the same period last year. The company also reported quarterly sales of $5.85 million, missing the analyst consensus estimate of $5.86 million by 0.20%. However, this is a 31.21% increase over sales from the same period last year.
August 11, 2023 | 11:01 am
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Biofrontera's Q2 earnings missed estimates with a larger than expected loss and slightly lower sales. However, sales have increased compared to the same period last year.
Biofrontera's Q2 earnings missed analyst estimates, which could negatively impact investor sentiment and potentially lead to a short-term decrease in the stock price. However, the increase in sales compared to the same period last year could mitigate this impact to some extent.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100